hemodialysis (HD).Secondary outcomes included peritonitis, major adverse cardiac events (MACE), and hospitalization burden.Outcomes were assessed throughout the PD duration, from the index date until event occurrence, death, HD transfer, kidney transplantation, or the end of follow-up (December 31, 2020 for APD; December 31, 2023 for RPM-APD).Results: Among 2,477 patients, the mean age was 53.6 years, 54.5% were male, and the mean follow-up was 2.0 years.In the IPTWadjusted cohort, RPM-APD was associated with lower risks of all-cause death (hazard ratio HR 0.82, 95% CI 0.69-0.99;P = 0.037) and HD transfer (subdistribution hazard ratio SHR 0.86, 95% CI 0.77-0.96;P = 0.007).These findings were consistent in the PSM cohort.The risks of peritonitis and MACE were similar between groups, but RPM-APD patients had fewer annual hospitalizations (rate ratio 0.70, 95% CI 0.68-0.73;P < 0.001). Conclusion:In this population-based real-world study, RPM-APD was associated with improved survival, reduced HD transfer, and fewer hospitalizations compared with conventional APD.These findings support the clinical value of remote patient management as an effective strategy to enhance peritoneal dialysis care.I have no potential conflict of interest to disclose.I did not use generative AI and AI-assisted technologies in the writing process.
Kanav Anand (Wed,) studied this question.